AT1-AA inhibition, by our inhibitory peptide, which consists of the seven amino acid sequence specific to the epitope binding site of AT1-AA to the AT1 receptor (‘n7AAc’), administered to RUPP rats during pregnancy improves blood pressure and many of the other pathophysiological factors associated with preeclampsia [39]. The gene discussed is AGTR1; the disease is preeclampsia.